FURTHER DETAILS ON CHANGES TO PHARMACEUTICAL QUALITY ASSURANCE POLICY
ABSTRACT Further details are provided regarding a Global Fund Board decision last month to modify the Fund's Quality Assurance Policy for Pharmaceutical Products.
By Bernard Rivers
December 18, 2009
121